Cargando…

Natural History of Pediatric Low-Grade Glioma Disease - First Multi-State Model Analysis

Background: Pediatric low-grade glioma [PLGG] is often a chronic progressive disease requiring multiple treatments, i.e. surgery, chemotherapy and irradiation. The multi-state model [MSM] allows an extended analysis of disease-states, that patients may undergo, incorporating competing risks over the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goebel, Anna-Maria, Gnekow, Astrid K., Kandels, Daniela, Witt, Olaf, Schmidt, Rene, Hernáiz Driever, Pablo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856735/ https://www.ncbi.nlm.nih.gov/pubmed/31772664 http://dx.doi.org/10.7150/jca.33463

Ejemplares similares

LGG-11. Analysis of neurosurgical complications in pediatric supratentorial midline low-grade glioma – results from the German LGG studies
por: Weiß, Sarah, et al.
Publicado: (2022)

Long-term cognitive deficits in pediatric low-grade glioma (LGG) survivors reflect pretreatment conditions—report from the German LGG studies
por: Traunwieser, Thomas, et al.
Publicado: (2020)

Response to trametinib treatment in progressive pediatric low-grade glioma patients
por: Selt, Florian, et al.
Publicado: (2020)

Second course of re-irradiation in pediatric diffuse intrinsic pontine glioma: A case study
por: Bergengruen, Paula Maria, et al.
Publicado: (2023)

LGG-14. LOGGIC (Low Grade Glioma in Children) Core BioClinical Data Bank: Establishment and added clinical value of an international molecular diagnostic registry for pediatric low-grade glioma patients
por: Hardin, Emily C, et al.
Publicado: (2022)

LGG-26. Predicting MAPK inhibitor sensitivity in pediatric low-grade gliomas with novel gene expression-derived signatures
por: Sigaud, Romain, et al.
Publicado: (2022)

A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report
por: Gnekow, Astrid K., et al.
Publicado: (2017)

LGG-09. CLINICAL ACTIVITY OF PAN-RAF INHIBITOR TOVORAFENIB IN THE REGISTRATIONAL PEDIATRIC LOW-GRADE GLIOMA ARM OF THE PHASE 2 FIREFLY-1 (PNOC026) STUDY
por: Kilburn, Lindsay, et al.
Publicado: (2023)

IMG-03. RESPONSE ASSESSMENT IN PEDIATRIC LOW-GRADE GLIOMA: RECOMMENDATIONS FROM THE RESPONSE ASSESSMENT IN PEDIATRIC NEURO-ONCOLOGY (RAPNO) WORKING GROUP
por: Fangusaro, Jason, et al.
Publicado: (2020)

MAPK inhibitor sensitivity scores predict sensitivity driven by the immune infiltration in pediatric low-grade gliomas
por: Sigaud, Romain, et al.
Publicado: (2023)

Corrigendum to “A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report” [Eur J of Canc (2017) 206–225]
por: Gnekow, Astrid K., et al.
Publicado: (2018)

Mapping of long-term cognitive and motor deficits in pediatric cerebellar brain tumor survivors into a cerebellar white matter atlas
por: Grosse, Frederik, et al.
Publicado: (2021)

ATRT-02. Neuropsychological function in infant atypical teratoid/rhabdoid tumor versus low-grade glioma survivors reflects tumor malignancy and multimodal treatment
por: Traunwieser, Thomas, et al.
Publicado: (2022)

Secondary dissemination in children with high-grade malignant gliomas and diffuse intrinsic pontine gliomas
por: Wagner, S, et al.
Publicado: (2006)

A Multi-Institutional Experience in Pediatric High-Grade Glioma
por: Walston, Steve, et al.
Publicado: (2015)

Biology and grading of pleomorphic xanthoastrocytoma—what have we learned about it?
por: Vaubel, Rachael, et al.
Publicado: (2020)

Pediatric Low-Grade Gliomas
por: Collins, Kelly L., et al.
Publicado: (2020)

Commentary on: “A Multi-Institutional Experience in Pediatric High Grade Glioma”
por: Caffo, Maria
Publicado: (2015)

LGG-16. NOVEL COMBINATION THERAPIES FOR PEDIATRIC LOW-GRADE GLIOMA AND CHARACTERIZATION OF THE UNDERLYING CELL DEATH MECHANISMS
por: Zeiser, Constantia, et al.
Publicado: (2023)

LGG-06. COMPREHENSIVE GENOMIC CHARACTERIZATION AND INTEGRATED CLINICAL ANALYSIS OF LOW-GRADE GLIOMAS IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1
por: Fisher, Michael, et al.
Publicado: (2021)

QOL-04. Histology, treatment, and extent of pretreatment hydrocephalus are major determents of neurocognitive outcome for survivors of pediatric posterior fossa tumors - report from the German HIT-studies
por: Neumann-Holbeck, Anne, et al.
Publicado: (2022)

Management of pineal region tumors in a pediatric case series
por: Schulz, Matthias, et al.
Publicado: (2020)

Long-term small-fiber neuropathy and pain sensitization in survivors of pediatric acute lymphoblastic leukemia after stem cell transplantation
por: Ruscher, Victoria, et al.
Publicado: (2020)

Integrated Multi-Omics Maps of Lower-Grade Gliomas
por: Binder, Hans, et al.
Publicado: (2022)

Correction to: Long-term small-fiber neuropathy and pain sensitization in survivors of pediatric acute lymphoblastic leukemia after stem cell transplantation
por: Ruscher, Victoria, et al.
Publicado: (2021)

NF1 optic pathway glioma: analyzing risk factors for visual outcome and indications to treat
por: Azizi, Amedeo A, et al.
Publicado: (2020)

Tumor load rather than contrast enhancement is associated with the visual function of children and adolescents with optic pathway glioma – a retrospective Magnetic Resonance Imaging study
por: Kilian, Anna, et al.
Publicado: (2022)

LGG-02. DRUG-CLASS SPECIFIC GENE-BASED MAPK SENSITIVITY SCORES (MSS) PREDICT SENSITIVITY TO MAPK INHIBITORS AND IDENTIFY IMMUNE INFILTRATION AS PUTATIVE TARGET IN PEDIATRIC LOW-GRADE GLIOMAS
por: Sigaud, Romain, et al.
Publicado: (2023)

Pediatric and Adult High-Grade Glioma Stem Cell Culture Models Are Permissive to Lytic Infection with Parvovirus H-1
por: Josupeit, Rafael, et al.
Publicado: (2016)

Medical Treatment of Pediatric Low-Grade Glioma
por: Lim, Yeon Jung
Publicado: (2022)

Chromatin mutations in pediatric high grade gliomas
por: Voon, Hsiao P. J., et al.
Publicado: (2023)

Cerebellar location may predict an unfavourable prognosis in paediatric high-grade glioma
por: Karremann, M, et al.
Publicado: (2013)

Molecular Biology in Pediatric High-Grade Glioma: Impact on Prognosis and Treatment
por: Rizzo, Daniela, et al.
Publicado: (2015)

Surgical Management of Pre-Chiasmatic Intraorbital Optic Nerve Gliomas in Children after Loss of Visual Function—Resection from Bulbus to Chiasm
por: Zipfel, Julian, et al.
Publicado: (2022)

LGG-17. Preventing recurrence: targeting molecular mechanisms driving tumor growth rebound after MAPKi withdrawal in pediatric low-grade glioma
por: Kocher, Daniela, et al.
Publicado: (2022)

Mediastinal mass in an tuberculosis-exposed 2-year old child with neurofibromatosis type 1 – TB or not TB?
por: Krüger, Renate, et al.
Publicado: (2020)

Mutations in chromatin machinery and pediatric high-grade glioma
por: Lulla, Rishi R., et al.
Publicado: (2016)

Pediatric low-grade glioma in the era of molecular diagnostics
por: Ryall, Scott, et al.
Publicado: (2020)

Predictors of Seizure Freedom in Pediatric Low-Grade Gliomas
por: Budnick, Hailey C, et al.
Publicado: (2022)

Pakistan National Guidelines for Pediatric High-Grade Gliomas
por: Bashir, Farrah, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fv3viuicoibunf8br484mvjttk